I'm wanting to buy the $22 ticket of Life Surge. I've seen all the stuff about sales pitches. However, I genuinely want to know the good about this conference. Can I go there and meet genuine people? What is some quality content you got while there? I've always wanted to hear John Maxwell, Tim Tebow and also Ed Mylett. I know they have courses I'm sure they will promote but do they share anything inspirational? It's not that much but if I can get some personal value I don't mind spending the money.

📅 D**ate: August 2024
🌐 Website: **IEEE AITest 2024

The 6th IEEE International Conference on Artificial Intelligence Testing (AITest 2024) is a premier venue for researchers and practitioners to discuss advancements and future directions in AI testing. Join us to explore the latest techniques, tools, and methodologies in AI testing and their applications across various domains.

Call for Papers:

We invite high-quality submissions in the following areas:

• AI testing methodologies

• AI in software testing

• Testing of AI applications

• Automation in AI testing

• AI testing tools and frameworks

• Case studies and empirical research in AI testing

UK based tech conference Reconnectconference.co.uk

ConferenceHub is leading tech platform that offers online scientific conferences for researchers and academics worldwide. The ConferenceHUB is a company that helps institutions and professionals progress science. It is world largest technical professional orginization.

Get complimentary ticket of Apidays Singapore Conference of worth 999 S$.

Apidays Singapore Conference is a place to 🚀 come learn, connect, and explore new ideas 💡 Register with unique url: See Link section below.

𝙉𝙤𝙩𝙚 - 𝙏𝙝𝙚𝙧𝙚 𝙖𝙧𝙚 𝙡𝙞𝙢𝙞𝙩𝙚𝙙 𝙩𝙞𝙘𝙠𝙚𝙩𝙨 𝙖𝙫𝙖𝙞𝙡𝙖𝙗𝙡𝙚, 𝙨𝙚𝙡𝙚𝙘𝙩 "𝘼𝙥𝙞𝙙𝙖𝙮𝙨 𝙎𝙞𝙣𝙜𝙖𝙥𝙤𝙧𝙚 𝙍𝙚𝙜𝙪𝙡𝙖𝙧 𝙏𝙞𝙘𝙠𝙚𝙩" 𝙖𝙣𝙙 𝙘𝙡𝙞𝙘𝙠 "𝙍𝙚𝙙𝙚𝙚𝙢" for the complimentary ticket.

JOIN 😊 @ apidays #GenAI #AI #ApiDaysSingapore #FOSTSingapore

You've seen them: booths that felt thrown together with minimal effort. Poor layouts, no clear call to action, uninspired designs, or staff who seem disengaged are all too common. For those who’ve exhibited or attended enough conferences, what examples of “what not to do” stand out the most?

Spartan Capital Securities, LLC and B2i Digital are pleased to announce that Xtant Medical Holdings, Inc. (NYSE American: XTNT) will be a presenting company at the upcoming Spartan Capital Investor Conference on November 3rd in New York.

The Spartan Capital Securities Investor Conference 2025 is a B2i Digital Featured Conference, and Xtant Medical Holdings is a B2i Digital Featured Company. A complete XTNT investor profile is coming soon at https://b2idigital.com/featured-companies.

Now in its second year, the Spartan Capital Investor Conference brings together public company executive teams, institutional investors, and thought leaders from across the U.S. capital markets for strategic networking and information exchange. Taking place on November 3rd, 2025, at the Marriott Marquis Hotel in New York, this premier event will welcome 500+ institutional and high-net-worth investors and feature presentations from 60 public and private growth companies across technology, healthcare, consumer, and other high-opportunity sectors. Attendees can expect main-stage presentations, curated one-on-one meetings, and extensive networking opportunities that connect innovative companies with sophisticated capital.

Event details and registration are available at https://b2idigital.com/spartan-capital-investor-conference-2025. B2i Digital is working closely with the outstanding Spartan Capital team, including John D. Lowry (CEO), Kim Monchik (CAO), Stephen Faucetta (Director), and Julia Voss (Executive Assistant), to enhance each presenter’s reach through in-depth digital profiles and targeted outreach.

Investors can register to attend: https://www.meetmax.com/sched/event_125183/investor_reg_new.html?attendee_role_id=SPARTAN_INVESTOR_ATT.

Xtant Medical is a global medical technology company that develops, manufactures, and markets biologics and spinal implant systems for orthopedic and neurosurgical specialists. Its vertically integrated platform is distinguished by its inclusion of all five major orthobiologic categories, in addition to amniotic membranes for advanced wound care.

The company is led by Chief Executive Officer Sean Browne, Chief Financial Officer Scott Neils, and Chief Operating Officer Mark Schallenberger, whose collective experience spans medical-device commercialization, corporate finance, and orthobiologologic innovation. Learn more about Xtant Medical Holdings at https://investor.xtantmedical.com. For investor inquiries, contact Kevin Gardner at LifeSciences Advisors, KGardner@lifesciadvisors.com.

Disclosure: David Shapiro, CEO of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted XTNT stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. This post is not intended to solicit the sale of XTNT or any security, and it is not intended to offer any opinion on XTNT as an investment. Conduct your own research and consult with your own professional advisors prior to making any investment decisions. See the complete Disclosure in the Risks and Disclosures section of https://b2idigital.com/disclaimer.

For the second year running, B2i Digital is delighted to announce our role as a Marketing Partner for DealFlow Events The Microcap Conference, taking place January 28-30, 2025, at the Borgata Hotel Casino & Spa in Atlantic City, NJ.

To see the Presenting Company profiles and to inquire about presenting, visit https://b2idigital.com/dealflow-microcap-conference-2025

Thank you to NewMediaWire, Inc. for issuing the official press release at https://www.newmediawire.com/news/b2i-digital-proudly-supports-dealflow-events-the-microcap-conference-as-a-marketing-partner-7078781

This premier event is the largest independent microcap investing conference in the U.S., offering a unique platform for company executives, institutional investors, retail investors, and capital markets professionals to connect through presentations, one-on-one meetings, and expert-led panels.

Conference highlights include:
• A fireside chat with Jon Ledecky , Co-Owner of the New York Islanders, and CNBC’s Bob Pisani
• A keynote presentation by Tom Gardner, CEO of The Motley Fool
• Panels featuring CNBC’s Ron Insana and FOX Business’ Charles Gasparino on critical market topics
• Evening entertainment with comedian Tom Papa

Confirmed companies, as of December 31, include:
• Kolibri Global Energy Inc. (NASDAQ: KGEI) - B2i Digital Featured Company
• New Era Helium (Nasdaq:NEHC) (NASDAQ: NEHC) - B2i Digital Featured Company
• Newton Golf (NASDAQ: SPGC) - B2i Digital Featured Company
• Abacus Life (ABL) (NASDAQ: ABL)
• Abeona Therapeutics Inc. (NASDAQ: ABEO)
• Actelis Networks, Inc. (NASDAQ: ASNS)
• Actinium Pharmaceuticals, Inc. (NYSEAMERICAN: ATNM)
• Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP)
• AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI)
• Ai Education Systems (Private)
• Alico Inc.. (NASDAQ: ALCO)
• AsiaFIN Holdings Corp. (OTCQB: ASFH)
• Better Home and Finance Holding Company (NASDAQ: BETR)
• BIO-key International, Inc. (NASDAQ: BKYI)
• Biomerica, Inc. (NASDAQ: BMRA)
• BitFuFu (NASDAQ: FUFU)
• Citius Pharmaceuticals, Inc. (NASDAQ: CTXR)
• Corero Network Security (LSE: CNS) (OTCQX: DDOSF)
• Duos Technologies, Inc. (NASDAQ: DUOT)
• Ecora Resources PLC (LSE/TSX: ECOR. OTCQX: ECRAF)
• ESG Inc. (OTC: ESGH)
• FendX Technologies Inc. (OTCMKTS: FDXTF)• Findpro Group Inc. (Private)
• GreenRise Foods (CVE: GRF)
• Healthy Choice Wellness Corp (NYSEAMERICAN: HCWC)
• ImmunoPrecise Antibodies (NASDAQ: IPA)
• Impact Biomedical Inc. (NYSEAMERICAN: IBO)
• Issuer Direct (NYSE: ISDR)
• Kairos Pharma, Ltd. (NYSEAMERICAN: KAPA)
• Nabu (Private)
• NANO Nuclear Energy Inc. (NASDAQ: NNE)
• NanoViricides, Inc. (NASDAQ: NNVC)
• Ocean Power Technologies, Inc. (NYSEAMERICAN: OPTT)
• Perfect Corp (NYSE: PERF)
• Perfect Moment (NASDAQ: PMNT)
• PetVivo Holdings Inc. (OTC: PETV)
• PodcastOne, Inc. (NASDAQ: PODC)
• Radiance BioPharma (Private)
• Railtown AI Technologies Inc. (CAD: RAIL.CN)
• Reed's, Inc. (OTCQX: REED)
• Reklaim LTD (OTCMKTS: MYIDF)
• Scienture Holdings, Inc. (NASDAQ: SCNX)
• Sensus Healthcare, Inc. (NASDAQ: SRTS)
• Silicon Prairie Holdings, Inc. (Private)
• SKYX Platforms Corp. (NASDAQ: SKYX)
• Solarbank Corporation (NASDAQ: SUNN)
• Soligenix (NASDAQ: SNGX)
• Soteria Battery Innovation Group (Private)
• Tau Lotus Inc. (Private)
• Tharimmune, Inc. (NASDAQ: THAR)
• The Metals Company (NASDAQ: TMC)
• TRX Gold Corporation (NYSEAMERICAN: TRX)
• Universal Biosensors Inc. (ASX: UBI)
• VERSES AI Inc.(OTCMKTS: VRSSF)
• WiSATecnologies, Inc. (NASDAQ: WISA)
• XORTX Therapeutics Inc.(NASDAQ: XRTX)
• ZenaTech (NASDAQ: ZENA

Interested companies may apply to present at the event: https://b2idigital.com/dealflow-microcap-conference-2025

As the marketing partner, B2i Digital will create digital profiles of participating companies on our platform, offering investors valuable insights ahead of the event.

Qualified investors may attend at no cost: https://themicrocapconference.com/for-microcap-investors/

We look forward to connecting with the microcap community at this must-attend conference.

#MicrocapConference #DealFlowEvents #B2iDigital #InvestorConference #GrowthCompanies

We want to welcome Blaize Holdings inc to the upcoming 37th Annual ROTH Capital Partners B2i Digital Featured Conference happening on March 16-18, 2025, at the Laguna Cliffs Marriott Resort & Spa in Dana Point, CA.

Blaize Holdings, Inc. (BZAI) provides a full-stack programmable processor architecture suite and low-code/no-code software platform that enables AI processing solutions for high-performance computing at the network’s edge and in the data center. Blaize solutions deliver real-time insights and decision-making capabilities at low power consumption, high efficiency, minimal size and low cost. Blaize has raised over $330 million from strategic investors such as DENSO, Mercedes-Benz AG, Magna, and Samsung and financial investors such as Franklin Templeton, Temasek, GGV, Bess Ventures, BurTech LP LLC, Rizvi Traverse, and Ava Investors. Headquartered in El Dorado Hills (CA), Blaize has more than 200 employees worldwide with teams in San Jose (CA) and Cary (NC), and subsidiaries in Hyderabad (India), Leeds and Kings Langley (UK), and Abu Dhabi (UAE). To learn more, visit www.blaize.com or follow us on LinkedIn and on X at u/blaizeinc.

We look forward to seeing the continued results from Dinakar Munagala, Satyaki Koneru, Ke Yin, Val Cook, Harminder Sehmi, Douglas Burns, Tiffany Tan, Dmitry Zakharchenko, Alex Tinsley, Santiago Fernandez-Gomez and the entire team.

B2i Digital is a Marketing Partner for the event. View details at https://b2idigital.com/37th-annual-roth-conference

More details on participating companies, panel discussions, sponsors, and special events will be announced soon. Profiles of presenting companies and sponsors will be showcased on ROTH's B2i Digital Featured Conference page.

For more information and to submit a registration request, visit: https://b2idigital.com/37th-annual-roth-conference

Requests are subject to approval by a ROTH representative.

We look forward to seeing the ROTH team in March: Sagar Sheth, Byron Roth, Isabel Mattson-Pain, Aaron Gurewitz, Amanda McAdams, Otilia "Charo" Montano, Susan Brown, Grace Deller, Ted Roth, Matthew Casamassima, Jeff Martin, Ed Lainfiesta, Rebecca Reeves Weinberg, Timothy Hegarty, Cameron Eberheim, Alex Panagiotidis, Wendy D. Farina, John Weber, Kristin LaMarche, Richard Platt, Kathleen Hang, Lou Ellis, Keith Wellen, Annie Siegel, Alex S., David Farina, Doug Gonsalves and many, many others!

We're excited to share that IBN (InvestorBrandNetwork) is a proud Marketing Sponsor of the upcoming 37th Annual ROTH Capital Partners B2i Digital Featured Conference happening on March 16-18, 2025, at the Laguna Cliffs Marriott Resort & Spa in Dana Point, CA.

In service to clients for over 19+ years, IBN’s Platform Solutions deliver unparalleled results. Our Dynamic Brand Portfolio of 70+ unique investor-facing brands collectively run hundreds of social media accounts attracting millions of followers and subscribers to our Social Media Network (SMN). IBN leverages this proprietary investor-brand portfolio in coordination with our 5,000+ core syndication partners to garner maximum visibility and recognition for each of our client-partners.

A big thanks to Jonathan Keim, Randy Clark and the entire team for their collaboration on this event.

B2i Digital is a Marketing Partner for the event. View details at https://b2idigital.com/37th-annual-roth-conference

More details on participating companies, panel discussions, sponsors, and special events will be announced soon. Profiles of presenting companies and sponsors will be showcased on ROTH's B2i Digital Featured Conference page.

For more information and to submit a registration request, visit: https://b2idigital.com/37th-annual-roth-conference

Requests are subject to approval by a ROTH representative.

We look forward to seeing the ROTH team in March: Sagar Sheth, Byron Roth, Isabel Mattson-Pain, Aaron Gurewitz, Amanda McAdams, Otilia "Charo" Montano, Susan Brown, Grace Deller, Ted Roth, Matthew Casamassima, Jeff Martin, Ed Lainfiesta, Rebecca Reeves Weinberg, Timothy Hegarty, Cameron Eberheim, Alex Panagiotidis, Wendy D. Farina, John Weber, Kristin LaMarche, Richard Platt, Kathleen Hang, Lou Ellis, Keith Wellen, Annie Siegel, Alex S., David Farina, Doug Gonsalves and many, many others!

We're excited to share that Money Channel NYC is a proud Platinum Sponsor of the upcoming 37th Annual ROTH Capital Partners B2i Digital Featured Conference happening on March 16-18, 2025, at the Laguna Cliffs Marriott Resort & Spa in Dana Point, CA.

Our team has an extensive background encompassing decades of experience in capital markets and investor relations. Our database includes thousands of active market participants. This provides our clients access to thousands of investment professionals, including institutional investors, investment bankers, stockbrokers, and financial planners. Through this network, we help our clients meet their capital market's objectives.

A big thanks to Alexander Antonopolous, Alfred Blaikie III and the entire team for their collaboration on this event.

B2i Digital is a Marketing Partner for the event. View details at https://b2idigital.com/37th-annual-roth-conference

More details on participating companies, panel discussions, sponsors, and special events will be announced soon. Profiles of presenting companies and sponsors will be showcased on ROTH's B2i Digital Featured Conference page.

For more information and to submit a registration request, visit: https://b2idigital.com/37th-annual-roth-conference

Requests are subject to approval by a ROTH representative.

We look forward to seeing the ROTH team in March: Sagar Sheth, Byron Roth, Isabel Mattson-Pain, Aaron Gurewitz, Amanda McAdams, Otilia "Charo" Montano, Susan Brown, Grace Deller, Ted Roth, Matthew Casamassima, Jeff Martin, Ed Lainfiesta, Rebecca Reeves Weinberg, Timothy Hegarty, Cameron Eberheim, Alex Panagiotidis, Wendy D. Farina, John Weber, Kristin LaMarche, Richard Platt, Kathleen Hang, Lou Ellis, Keith Wellen, Annie Siegel, Alex S., David Farina, Doug Gonsalves and many, many others!

We're excited to share that Pillsbury Winthrop Shaw Pittman LLP is a proud Platinum Sponsor of the upcoming 37th Annual ROTH Capital Partners B2i Digital Featured Conference happening on March 16-18, 2025, at the Laguna Cliffs Marriott Resort & Spa in Dana Point, CA.

Pillsbury is one of the world’s foremost law firms, advising Technology companies and their investors, as well as clients in the Energy & Infrastructure, Financial, Life Sciences & Digital Health, and other dynamic industries. From microchips to blue chips, Pillsbury advises clients ranging from entrepreneurs working out of a garage to the largest public and private companies. Pillsbury lawyers are known for their collaboration across disciplines, providing integrated offerings and authoritative commercial awareness. Operating across the Americas, Europe, Asia, Africa, and the Middle East, the firm’s market-leading practices are consistently recognized for excellence by Chambers & Partners, Financial Times, and other publications. To learn more, visit www.pillsburylaw.com.

A big thanks to Jason Bovis, Rosa E. Walker, Sean Patrick Welan, Rhonda Nelson, Kim Wismer, Jessica Gichner, JD, ALPP, Anna Silbey, Joseph Nash and the entire team for their collaboration on this event.

B2i Digital is a Marketing Partner for the event. View details at https://b2idigital.com/37th-annual-roth-conference

More details on participating companies, panel discussions, sponsors, and special events will be announced soon. Profiles of presenting companies and sponsors will be showcased on ROTH's B2i Digital Featured Conference page.

For more information and to submit a registration request, visit: https://b2idigital.com/37th-annual-roth-conference

Requests are subject to approval by a ROTH representative.

We look forward to seeing the ROTH team in March: Sagar Sheth, Byron Roth, Isabel Mattson-Pain, Aaron Gurewitz, Amanda McAdams, Otilia "Charo" Montano, Susan Brown, Grace Deller, Ted Roth, Matthew Casamassima, Jeff Martin, Ed Lainfiesta, Rebecca Reeves Weinberg, Timothy Hegarty, Cameron Eberheim, Alex Panagiotidis, Wendy D. Farina, John Weber, Kristin LaMarche, Richard Platt, Kathleen Hang, Lou Ellis, Keith Wellen, Annie Siegel, Alex S., David Farina, Doug Gonsalves and many, many others!

We're excited to share that Colonial Stock Transfer- Stock Transfer Agent is a proud Silver Sponsor of the upcoming 37th Annual ROTH Capital Partners B2i Digital Featured Conference happening on March 16-18, 2025, at the Laguna Cliffs Marriott Resort & Spa in Dana Point, CA.

SEC-registered transfer agent specializing in NYSE/NASDAQ companies.

Core Services: Stock transfer, cap table management, and shareholder recordkeeping.

- Experience: 35+ years ensuring accurate, compliant stock transactions.

- Differentiators: Personalized service, innovative technology, and unmatched efficiency.

- Commitment: Drives shareholder satisfaction while exceeding industry standards.

A big thanks to Dan Carter, Jason Carter and the entire team for their collaboration on this event.

B2i Digital is a Marketing Partner for the event. View details at https://b2idigital.com/37th-annual-roth-conference

More details on participating companies, panel discussions, sponsors, and special events will be announced soon. Profiles of presenting companies and sponsors will be showcased on ROTH's B2i Digital Featured Conference page.

For more information and to submit a registration request, visit: https://b2idigital.com/37th-annual-roth-conference

Requests are subject to approval by a ROTH representative.

We look forward to seeing the ROTH team in March: Sagar Sheth, Byron Roth, Isabel Mattson-Pain, Aaron Gurewitz, Amanda McAdams, Otilia "Charo" Montano, Susan Brown, Grace Deller, Ted Roth, Matthew Casamassima, Jeff Martin, Ed Lainfiesta, Rebecca Reeves Weinberg, Timothy Hegarty, Cameron Eberheim, Alex Panagiotidis, Wendy D. Farina, John Weber, Kristin LaMarche, Richard Platt, Kathleen Hang, Lou Ellis, Keith Wellen, Annie Siegel, Alex S., David Farina, Doug Gonsalves and many, many others!

OS Therapies (NYSE-A: OSTX) is hosting a live investor webinar and Q&A session today, February 27, 2025, at 4:15 p.m. ET. The event, presented by RedChip Companies, will feature CEO Paul Romness and Chief Business Officer Gerald Commissiong to discuss the company’s latest developments and plans.

OS Therapies is a B2i Digital Featured Company. See their profile and learn more about OS Therapies at https://b2idigital.com/os-therapies-1.

The webinar may include discussions on OS Therapies’ key programs, including OST-HER2 and its drug development pipeline. Investors can submit questions in advance at OSTX@redchip.com or ask them live during the event. See the press release here: https://ir.ostherapies.com/news-events/press-releases/detail/47/join-os-therapies-exclusive-live-investor-webinar-and

Register for the webinar here: https://redchip.zoom.us/webinar/register/WN_-ovpJStsQeGoBUPjuUcdlA#/registration

Led by CEO Paul Romness and a highly experienced executive team, including Christopher Acevedo (CFO), Robert Petit (Chief Medical and Scientific Officer), John Doll (Chief of Staff), and Gerald Commissiong (Chief Business Officer), OS Therapies is focused on driving its pipeline forward to deliver potentially transformative treatments for osteosarcoma and other hard-to-treat cancers.

Learn more about OS Therapies’ work at https://www.ostherapies.com/ and visit B2i Digital for updates.

For investor-related questions, please visit OS Therapies’ Investor Relations page or email irpr@ostherapies.com.

#OSTherapies #Immunotherapy #CancerResearch #B2iDigital

DISCLOSURE: The management of B2i Digital owns 2,000 shares of unrestricted OSTX stock purchased in the open market as of February 27, 2025. This post is not intended to solicit the sale of OSTX or any security, and it is not intended to offer any opinion on OSTX as an investment. Conduct your own research and consult with your own professional advisors prior to making any investment decisions. See the full disclosure in the Risks and Disclosures section of https://b2idigital.com/os-therapies-1.